垂体腺苷酸环化酶激活多肽 (PACAP) 是一种 38 个氨基酸,c 端 α 酰胺肽,可从绵羊下丘脑提取物中分离出来,基于其刺激垂体前叶细胞 cAMP 形成的能力。PACAP 属于血管活性肠多肽 (VIP) -分泌素-生长激素-释放激素-胰高血糖素超家族。在从原脊索动物到哺乳动物的进化过程中,PACAP 的序列保存得非常好。PACAP 广泛分布于脑和外周器官,主要分布于内分泌、胰腺、性腺、呼吸道和泌尿生殖道。PACAP 结合位点有两种类型:I 型结合位点对PACAP具有高亲和力,对 VIP 的亲和力低得多,而 II 型结合位点对 PACAP 和 VIP 都具有相似的亲和力。
对 PACAP 受体的分子克隆表明,存在三种不同的受体亚型:与多种转导系统偶联的 PACAP 特异性的PAC1-R,以及与 PACAP/ vip 无关的 VPAC1-R 和 VPAC2-R,主要与腺苷酸环化酶偶联。PAC1-Rs 在脑、垂体和肾上腺中含量特别丰富,而 VPAC 受体主要在肺、肝和睾丸中表达。
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38-amino acid, C-terminally alpha-amidated peptide that can be isolated from an ovine hypothalamic extract based on its ability to stimulate cAMP formation in anterior pituitary cells. PACAP belongs to the vasoactive intestinal polypeptide (VIP)-secretin-growth hormone-releasing hormone-glucagon superfamily. The sequence of PACAP has been remarkably well conserved during evolution, from protochordates to mammals. PACAP is widely distributed in the brain and peripheral organs, notably in the endocrine pancreas, gonads, and the respiratory and urogenital tracts. Two types of PACAP binding sites have been characterized: type I binding sites exhibit a high affinity for PACAP and a much lower affinity for VIP, whereas type II binding sites have a similar affinity for both PACAP and VIP.
Molecular cloning of PACAP receptors has shown the existence of three distinct receptor subtypes: the PACAP-specific PAC1-R, which is coupled to several transduction systems, and the PACAP/VIP-indifferent VPAC1-R and VPAC2-R, which are primarily coupled to adenylyl cyclase. PAC1-Rs are particularly abundant in the brain, pituitary, and adrenal gland, whereas VPAC receptors are expressed mainly in the lung, liver, and testis[1].
Maxadilan 是一种特异性不可逆 PAC1 受体激动剂,也是一种存在于白蛉唾液腺中的强效血管扩张肽,在 hADSCs 中表现出抗凋亡活性,可抑制促炎细胞因子 (TNF-α) 并增强抗炎介质 (IL-10),通过 PAC1 受体活化白细胞和抑制血管通透性,促进人类脂肪干细胞的神经分化,可用于研究内毒素休克、动脉粥样硬化和神经退行性疾病。
Ro 25-1553 是一种选择性 VIP2 受体 (VPAC2 receptor) 激动剂,对神经诱发或 Carbachol (MS-U27390) 诱发的气管平滑肌收缩具有支气管扩张作用,与 Formoterol、Salmeterol (MS-H94648) 联用可产生叠加效应,可用于支气管收缩的研究。
Ro 25-1553 acetate 是一种选择性 VIP2 受体 (VPAC2 receptor) 激动剂,对神经诱发或 Carbachol (MS-U27390) 诱发的气管平滑肌收缩具有支气管扩张作用,与 Formoterol、Salmeterol (MS-H94648) 联用可产生叠加效应,因此 Ro 25-1553 可用于支气管收缩的研究。
Ro 25-1553 TFA 是一种由 31 个氨基酸组成的血管活性肠肽 (VIP) 类似物,作为 VIP2 受体 (VPAC2 receptor) 激动剂,在豚鼠模型中对神经诱发或 Carbachol (MS-U27390) 诱发的气管平滑肌收缩表现出支气管扩张作用。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号